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Abstract There is a growing need for successful bone
tissue engineering strategies and advanced biomaterials that
mimic the structure and function of native tissues carry great
promise. Successful bone repair approaches may include an
osteoconductive scaffold, osteoinductive growth factors,
cells with an osteogenic potential and capacity for graft
vascularisation. To increase osteoinductivity of biomateri-
als, the local combination and delivery of growth factors has
been developed. In the present study we investigated the
osteogenic effects of calcium phosphate (CaP)-coated nano-
fiber mesh tube-mediated delivery of BMP-7 from a PRP
matrix for the regeneration of critical sized segmental bone
defects in a small animal model. Bilateral full-thickness
diaphyseal segmental defects were created in twelve male
Lewis rats and nanofiber mesh tubes were placed around the
defect. Defects received either treatment with a CaP-coated
nanofiber mesh tube (n06), an un-coated nanofiber mesh
tube (n=6) a CaP-coated nanofiber mesh tube with PRP
(n=6) or a CaP-coated nanofiber mesh tube in combination
with 5 μg BMP-7 and PRP (n06). After 12 weeks, bone
volume and biomechanical properties were evaluated using
radiography, microCT, biomechanical testing and histology.
The results demonstrated significantly higher biomechanical
properties and bone volume for the BMP group compared to
the control groups. These results were supported by the his-
tological evaluations, where BMP group showed the highest
rate of bone regeneration within the defect. In conclusion,
BMP-7 delivery via PRP enhanced functional bone defect
regeneration, and together these data support the use of
BMP-7 in the treatment of critical sized defects.
Keywords Bone defect . Bone tissue engineering . Growth
factors . Bone morphogenetic protein . Nanofiber mesh
Introduction
Bone is a dynamic and multifunctional organ, with remark-
able capacity for self-repair. However, in certain cases,
where healing and repair functions are impaired, surgical
therapeutic intervention is required due to a limited intrinsic
regeneration potential (Perry 1999). For challenging cases,
such as open fractures and large bone defects, tissue engi-
neering has emerged as a promising approach to bone re-
generation. For these situations, important considerations
include an osteoconductive scaffold, growth factors, vascu-
larisation of the graft and supply of cells with osteogenic
potential.
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The development of appropriate biomaterials for tissue
regeneration has become a key research drive in bone tissue
engineering. Most biomaterials suffer from limited bioactiv-
ity and therefore must be used in combination with osteoin-
ductive supplements. One of the most frequently used
techniques for overcoming lack of osteoinductivity is the
local delivery of growth factors, such as members of the
bone morphogenetic protein (BMP) family, vascular endo-
thelial growth factors (VEGF) and transforming growth
factor- ß (TGF-ß) (Xiao et al. 2011).
Among these growth factors, BMPs have been shown to
play an important role in osteogenic differentiation. In 1965,
Urist’s discovery of the osteoinductive capacity of the demin-
eralised bone matrix brought attention to the role of growth
factors found within the matrix (Urist 1965). Subsequently,
more than 15 osteogenic proteins or BMPs have been discov-
ered. Each of these proteins play a specific agonistic and/or
antagonistic action in the progressive stages of bone callus
formation (Kloen et al. 2002; Pazzaglia et al. 1988). Their
potential to induce osteogenic cell differentiation has been
shown in numerous in vitro and in vivo studies (Heckman et
al. 1991; Heckman et al. 1999; Johnson and Urist 1989; John-
son et al. 1990; Reichert et al. 2010). Based on these findings,
the two most promising BMPs [BMP-7 (also known as Oste-
ogenic Protein-1, OP-1) andBMP-2] have been produced using
recombinant DNA technology for clinical application (Ozkay-
nak et al. 1990). They have been approved by the FDA for use
in human spinal fusion, oral-maxillofacial applications and the
treatment of certain fractures (De Biase and Capanna 2005;
Friedlaender et al. 2001; Govender et al. 2002).
Nevertheless, the use of these commercially available
BMP products is limited, due to the suboptimal delivery
system (collagen type I matrix as a carrier), a short protein
half-life with difficult dosage control and the need for very
high, supraphysiological concentrations of BMP. These high
dosages of BMP have resulted in high costs for the clinical
application and are not without associated complications
(Garrison et al. 2007; Shields et al. 2006).
In the light of these aforementioned limitations asso-
ciated with current BMP delivery systems and to move
towards lowering the dosage and related costs of BMP
delivery, several different delivery vehicles have been
developed. For the regeneration of segmental long bone
defects, a hybrid nanofiber mesh/hydrogel delivery sys-
tem has been developed to provide spatiotemporal con-
trol of protein delivery (Boerckel et al. 2011; Kolambkar
et al. 2011). The investigators used the nanofiber mesh
tube, in combination with alginate hydrogels and differ-
ent BMP concentrations, to evaluate the release profile of
the alginate hydrogel and ascertain the effect of protein
dose on BMP-mediated bone regeneration. The nanofiber
mesh tubes served as a barrier retaining the alginate and
the delivered BMPs within the bone defect, thereby
promoting mineralized matrix formation, preventing
extra-anatomical mineralization and serving to target
and guide bone formation within the anatomical site
(Boerckel et al. 2011; Kolambkar et al. 2011). However,
a large amount of residual alginate was still present in
the defect 3 months after implantation, which may im-
pede remodelling and restoration of native architecture.
Therefore, in this current study we utilized platelet-rich
plasma (PRP) instead of alginate. PRP is a concentrated
source of autologous platelets and thus may be used as
an autologous fibrin glue system. In humans, PRP has
been investigated for several types of treatments, includ-
ing nerve injury, tendonitis, myocardial injury, orthope-
dics and dentistry (Hildner et al. 2011; Lee et al. 2011).
In order to increase the proliferative and osteoconductive
properties of the nanofiber mesh tubes, mineralizing the
mesh with a layer of apatite coating is considered to be a
promising approach. Comprehensive in vitro and in vivo
studies have demonstrated the positive influence of biomi-
metic apatite coating on the proliferative and osteoconduc-
tive properties of PLGA scaffolds (Davies et al. 2010). A
comprehensive review was compiled by Kretlow and Mikos
(Kretlow and Mikos 2007).
Taking into account these variations to the nanofiber
tubes, we therefore investigated the use of CaP-coated nano-
fiber mesh tube-mediated delivery of BMP-7 from a PRP
matrix for the regeneration of critical-sized segmental bone
defects in a small animal model.
Material and methods
Fabrication of nanofiber meshes
Nanofiber meshes were produced using electrospinning and
formed into cylindrical tubes as described previously
(Boerckel et al. 2011; Kolambkar et al. 2011; Oest et al.
2007). Briefly, poly-(ε-caprolactone) (PCL) was dissolved
at a concentration of 12% (w/v) in a 90:10 volume ratio of
hexaflouro-2-propanol:dimethylformamide (Sigma-Aldrich)
and electro-spun onto a static collector. Twenty-four 1-mm
diameter perforations were patterned into the nanofiber
mesh sheets, which were then glued into tubes of 4.5 mm
diameter and 12 mm length. The nanofiber meshes were
immersed in ethanol for 30 min under vacuum and then
placed into a 2 M natrium hydroxide (NaOH) solution pre-
heated at 37°C in a water bath. A 5-min vacuum treatment
was performed in order to facilitate the solution penetration
in the depth of the mesh and therefore the efficacy of the
alkaline etching. After 30 min at 37°C, the meshes were
rinsed five times with ultra-pure water until a neutral pH
was reached. Mineralisation of the meshes by a layer of
calcium phosphate was performed through exposure to
604 Cell Tissue Res (2012) 347:603–612
simulated body fluid (SBF) prepared according to Yang et
al. (Yang et al. 2008), with the exception that the pH was
adjusted to 6 to increase the solution stability and to delay
calcium phosphate precipitation in the solution. Yang et al.
showed that using a 10× SBF resulted in the formation of a
mixture of nano-apatite and di-calcium phosphate dehy-
drate. Therefore, it was expected that the coating formed
in this present study should be of the same nature, as our
experimental conditions did not show any significant differ-
ences. SBF solution was filtered with 0.2 μm filters before
immersing the meshes. A further 5-min vacuum treatment
was then performed to enable infiltration of the SBF solu-
tion into the mesh. Thereafter, the meshes were placed at
37°C for 2.5 h, with SBF refreshed every 30 min. A 0.5 M
NaOH post-treatment for 30 min at 37°C was performed in
order to obtain a homogenous calcium phosphate phase. The
meshes were then rinsed five times in ultra-pure water, air
dried for 4 h and sterilized by using UV light for 1 h. The
surface coating was visualized using scanning electron mi-
croscopy (SEM) and microCT (Fig. 1). Nanofiber meshes
were kept in sterile tubes in a dessicator until use.
Loading of growth factors to nanofiber meshes
Sterile pulverized bone morphogenetic protein-7 (BMP-7,
Stryker®, USA) was used in this experiment. 5 μg of BMP-
7 was reconstituted in 120 μl of platelet-rich plasma (PRP)
and activated with 60 μl of thrombin (200 U/ml). To produce
PRP, 10 ml of blood was collected from donor rats not
included in this experiment. The blood was collected in 3.5-
ml monovettes, supplemented with sodium citrate (3.8%) and
then transferred to falcon tubes and centrifuged for 20 min at
2.400 rpm. Subsequently, the yellow plasma of the tube was
transferred to another 15-ml falcon tube and platelets pelleted
in a second centrifugation step for 10 min at 3,600 rpm
(Weibrich et al. 2001). The pellet was resuspended in 0.3 ml
of plasma and the platelets counted in a Neugebauer counting
chamber. After preparation, PRP was mixed with the BMP-7,
activated by adding thrombin (200U/ml) and then loaded onto
the sterilized nanofiber mesh tubes. The PRP layer on the
surface of the meshes was visualized using SEM (Fig. 2).
The nanofiber meshes were placed in an incubator at 37°C
for at least 1 hour before implantation into the defect.
Fig. 1 For uncoated meshes,
the individual fibres could be
identified using SEM (a). After
coating of the nanofiber
meshes, a homogenous calcium
phosphate layer was visualised
on the surface using SEM (b/c).
MicroCT scanning revealed the
overall mineralisation on the
surface (e) and across the
meshes (f) on the coated
meshes, whereas no signal was
detected on the non-coated
meshes (d)
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Surgical procedure/experimental groups
Twelve skeletally mature male Lewis rats with a mean
bodyweight of 306 g (STDV 25 g) were obtained from
Animal Resources Centre, Canning Vale, WA, USA. The
rats were housed at the QUT Medical Engineering Research
Facility (MERF) at the Prince Charles Hospital, Chermside.
The animals received water and pelleted ration ad libitum
throughout the experiment. All procedures were approved
by the animal ethics committee of the Queensland Univer-
sity of Technology. All rats were operated under general
anaesthesia, administered through intraperitoneal injection
of a mixture of ketamine and xylazine (75-100 mg/kg ket-
amine +5-10 mg/kg xylazine). Buprenorphine (0.01–
0.05 mg/kg subcutaneously) was used for analgesia pre-
operatively and post-operatively every 6–12 hours for
3 days. Using an anterior approach, bilateral incisions were
made over the length of the femurs (Fig. 3a). Prior to defect
creation, the femora were stabilized by modular fixation
plates consisting of a polysulfone plate and two stainless
steel plates (J.I. Morris Co., Southbridge, MA, USA)
(Fig. 3b/c). Bilateral full-thickness diaphyseal segmental
defects (8 mm long) were created using a miniature oscil-
lating saw and flushed with saline (Fig. 3d/f) (Oest et al.
2007). Nanofiber mesh tubes were placed around the adja-
cent bone ends such that the tube lumen contained the defect
and there was an overlap of 2.5 mm with the native bone
ends at each end of the tube (Fig. 3f). Defects received
treatment either with uncoated nanofiber mesh tubes (n0
6), CaP-coated nanofiber mesh tubes (n06; mesh-coated
group), CaP-coated nanofiber mesh tubes with PRP (n06)
or CaP-coated nanofiber mesh tubes with BMP-7 (5 μg) and
PRP (n06; BMP group). Furthermore, six femora of unop-
erated rats from the same breed served as a control group for
microCT analysis and biomechanical testing (n06; control
group). The groups were assigned to the right and left limbs
to evenly distribute pairs of groups and obtain a balanced
experimental design. During anaesthesia, surgery and im-
mediate post-operative period, the rats were kept on a heat-
ing pad and after that, they were transferred to a clean
warmed cage for recovery. After surgery, the animals were
allowed to recover and move freely. Animals were kept for
12 weeks after surgery and then sacrificed by CO2 inhala-
tion. To collect the implants, the skin was dissected, both
femora of the rats were removed and wrapped in phosphate
buffered saline (PBS)-soaked gauze and frozen at −20°C
until further analysis.
Radiographic and microcomputed tomography analysis
(microCT)
After 12 weeks, planar radiographs of the femora were taken
in two orientations to qualitatively assess bone regeneration
and bridging of the defect. For quantitative evaluation of
bone formation, the bones were scanned in a micro-
computed tomography scanner (microCT 40, Scanco Med-
ical, Brüttisellen, Switzerland) at an energy of 55 kVp and
intensity of 145 μA with 200 ms integration time. For
further processing, a threshold of 313.5 mg HA/ccm and a
Gauss filter with a filter width of 0.8 and filter support of 1.0
was applied to the scans. X-ray attenuation was correlated to
sample density using a standard curve generated by scan-
ning hydroxyapatite phantoms with known mineral densi-
ties. Mineralized matrix volume and bone volume fraction
were quantified throughout the entire construct and pre-
sented as bone volume in mm3. In addition, the polar mo-
ment of inertia (pMOI) in mm4 was calculated for the defect
zone. The pMOI represents a quantity used to predict an
object’s ability to resist torsion. Six femora of non-operated
rats with the same bodyweight served as control values for
bone volume and polar moment of inertia.
Fig. 2 The nanofiber mesh tubes (a; bar01 mm) were loaded with
5 μg BMP-7 in combination with PRP. Due to the freeze-drying
processing for SEM, the PRP layer flaked off in several areas (b;
arrows indicate flakes, bar01 mm). Higher magnification shows the
homogenous PRP layer on the mesh surface, with several thrombo-
cytes connected with small fibrin fibres (c; arrows indicate thrombo-
cytes, bar05 μm)
606 Cell Tissue Res (2012) 347:603–612
Biomechanical testing
After thawing, the bone ends were carefully cleaned of
soft tissue and embedded in plastic cups using polyme-
thylmethacrylate (PMMA) (Paladur, Heraeus Kulzer,
Germany). Throughout the preparation, embedding and
testing, the bones were kept moist by wrapping them in
phosphate buffered saline (PBS) soaked gauze. The
embedded bones were then inserted into a custom
designed torsion testing set-up for an Instron 5848
Microtester (Instron, Norwood, MA, USA). One end
of the bone was fixed, while the other end rotated at
0.58°/s, while torsion angle and torque were recorded.
Each bone was tested three times to 2° rotation to
determine torsional stiffness and then once until failure
to determine torsional strength. Both femora from each
animal were tested, with the testing orientation changed
for the two bones to ensure testing them in internal
rotation, similar to physiological loading. Outcome
parameters were calculated in terms of absolute values
(torsional stiffness in Nmm/degree, ultimate torque in
Nmm) and in percentages for treated bones compared to
the six non-operated rat femora, which served as intact
control bones.
Histological analysis
For processing decalcified samples into paraffin, the femora
were fixed in 10% neutral buffered formalin for 24 h and
decalcified in 15% EDTA for 3 weeks at 4°C. The samples
were then serially dehydrated in ethanol in a tissue processor
(Excelsior ES, Thermo Scientific, Franklin, MA, USA) and
embedded in paraffin. Sections (5 μm) were taken using a
microtome (Leica RM 2265). The slides were then depar-
affinized with xylene and rehydrated with serial concentra-
tions of ethanol, before being stained with haematoxylin and
eosin (Sigma-Aldrich) and mounted with Eukitt mountant
(Fluka Biochemica, Milwaukee, WI, USA). Selected femora
were excised and fixed in 10% neutral buffered formalin for
24 h and changed to 70% ethanol prior to embedding in hard
resin (methylmethacrylate, MMA, Sigma Aldrich) to assess
the specimens in their non-decalcified state. Longitudinal
sections were cut to a thickness of 6 μm using a Leica
SL2500 Sledge Microtome and were stained using von
Kossa–MacNeal's tetrachrome to identify new bone
formation.
Statistics
Statistical analysis was performed for all the quantitative
results using Student’s t-test for comparing means from two
independent sample groups. A confidence level of 95% was
used (p<0.05). All values are displayed as mean values with
standard deviation of means.
Results
After 12 weeks, all animals were euthanized and both fem-
ora were removed for further evaluations. Macroscopic
evaluation of the femurs showed a good integration of the
nanofiber mesh tubes to the bone and the surrounding tis-
sues (Fig. 4a). The groups treated with the CaP-coated
nanofiber mesh tubes with PRP and the uncoated nanofiber
Fig. 3 The skin incision was made antero-lateral at the femur. After
cutting through the fat pad, a blunt dissection of the vastus lateralis of
the quadriceps was performed (a). After exposing the bone, the pre-
pared plate (e; arrow indicates defect size of 0.8 cm, bar00.5 cm) was
inserted and fixed with the holder (b). The holes were carefully drilled,
beginning with the most proximal followed by the most distal hole (c).
After sawing the 8-mm segmental defect (d), the bone piece was
removed and the soft-tissue protector inserted (f; arrow indicates seg-
mental bone defect). The mesh tubes were carefully inserted with cover-
ing the host bone on both sides (g; asterisk indicates nanofiber mesh tube)
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mesh tubes did not show any significant differences in the
microCT and biomechanical analysis compared to the CaP-
coated mesh tubes without PRP (mesh-coated group).
Hence, the data of these two groups are not shown.
Radiographic analysis
The radiographs of the defect region showed a complete
bridging of the defect, with bone regeneration throughout
the defect, for all samples in the BMP group after 12 weeks
(Fig. 4b/c). The mineral density of the regenerated tissue
appeared lower compared to the adjacent host bone. In the
mesh-coated group, no bridging of the defects was seen in
any animal up to 12 weeks (Fig. 4d/e), although small
amounts of regenerated bone tissue were detected growing
from the proximal and distal host bone ends.
microCT analysis
The results of the qualitative evaluation of the bridging of
the defects using three-dimensional rendering of the pro-
cessed microCT were consistent with those of the two-
dimensional radiographic analysis (Fig. 5a/b). A significant-
ly higher volume of newly formed bone was found in the
BMP-group compared to the mesh-coated group (Fig. 5d).
Comparison values for bone volume and polar moment of
inertia from unoperated control femora showed slightly
more bone volume compared to the BMP-group (not
Fig. 4 The nanofiber mesh
tubes showed a good
integration into the defect site
and the surrounding tissues (a).
Representative X-ray images in
two planes, of the BMP-group
(b/c) and the coated mesh group
(d/e) after 12 weeks. Complete
bone regeneration and defect
bridging could be observed in
the BMP group, whereas just a
small amount of bone regener-
ation without defect bridging
occurred in the mesh group
Fig. 5 Representative 3D
microCT reconstructions of the
complete defect zone from the
mesh (coated) group (a; bar0
1 mm) and the BMP group (b;
bar01 mm). Bone regeneration
was observed throughout the
defect in the BMP group (b),
whereas the mesh (coated)
group showed just a small
amount of regenerated bone
within the defect (a). Values for
the polar moment of inertia
showed the same trend as the
results for bone volume (c).
Bone volume calculations
showed significantly more bone
formed in the BMP group than
in the mesh (coated) group (d).
Asterisks indicate statistical
significance. Six femora of non-
operated rats served as control
values
608 Cell Tissue Res (2012) 347:603–612
significant). The results for the polar moment of inertia
predicted a better mechanical integrity of the bones of the
BMP group than the mesh-coated group, whereas no signif-
icant difference to the unoperated control femora could be
determined (Fig. 5c).
Biomechanical testing
Biomechanical properties of the regenerated femurs were
obtained from torsional testing at 12 weeks and compared to
control femurs from animals of the same breed and age, not
undergoing surgical procedures. The maximum torque at
failure of the BMP group was not significantly different
from intact controls, though the mean failure torque was
approximately 50–60% of the control values (Fig. 6a). The
maximum torque values of the mesh coated group were
significantly lower than both the BMP group and intact
controls, at 5% of the control group, reflecting the poor
bridging results from the radiographic analysis. Both the
BMP group and intact controls were significantly higher
than the mesh coated group (Fig. 6a). The torsional stiffness
of the BMP group was not significantly different from intact
controls and both were significantly greater than the mesh-
coated group (Fig. 6c).
Histology
Histological examinations of decalcified samples were per-
formed after 12 weeks. Representative H&E staining dem-
onstrated clear defect bridging within the BMP group
(Fig. 7a, c, d), whereas the mesh-coated group showed just
a small formation of new bone tissue (Fig. 7b, e, f). The
overview images of the longitudinal sections demonstrate
the whole defect site with the adjacent host bone (Fig. 7a/b).
The nanofiber mesh tubes showed, in both groups, a good
integration to the host bone and can be clearly visualised in
pale pink surrounding the dark pink host bone in the H/E
Fig. 6 Biomechanical testing
of the maximum torque at
failure (a) and torsional
stiffness (c) of the experimental
groups in relation to unoperated
controls (n06 per group). The
femora were embedded in
plastic moulds and the plate for
stabilizing the defect was
removed before testing (b/d).
Asterisks indicate statistical
significance
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overview images (Fig. 7a/b). In both groups, the newly
formed bone tissue was located within the mesh tubes.
Undecalcified resin sections were stained with von Kossa–
MacNeal's staining to identify new mineral deposition. The
BMP group showed a higher mineralisation within the defect
compared to the mesh-coated group (Fig. 7g-j). These results
reflect our microCT evaluation and demonstrate some regen-
erated bone tissue growing from the proximal and distal host
bone ends in the case of the coated mesh alone (Fig. 7i), which
mirrored the observations from the X-ray. Supplementary
Figure 1 depicts a histological assessment of an uncoated
mesh tube without PRP or BMP to demonstrate the fact that
the coating was playing a role in the bone regeneration, as the
uncoated meshes predominantly were filled with fibrous tis-
sue with limited bone formation.
Discussion
In the present study, we used a challenging rat femoral segmen-
tal defect model, developed by the Guldberg lab to evaluate
bone tissue engineering strategies. We investigated the osteo-
genic effects of calcium phosphate CaP-coated nanofiber mesh
tube-mediated delivery of BMP-7 from a PRPmatrix. Together,
these data demonstrate the capacity of PRP to act as a delivery
vehicle for recombinant proteins and the efficacy of BMP-7 to
induce bone regeneration.
The ongoing need for scaffolds in bone engineering is
driven by several factors. Firstly there is a surgical require-
ment to either augment or, alternatively, to avoid reliance upon
traditional autograft procedures, which are common practice
in orthopedic surgery but are frequently limited by insufficient
tissue availability. Secondly there is a need to address the
shortcomings of existing materials that may show limited
degradation in vivo, an architecture that does not reflect that
of the natural tissue, or a porosity and interconnected macro-
porosity that limits host tissue invasion and sustainable vas-
cularization. Next to the requisite structural properties of the
scaffold, the advent of tissue engineering strategies to increase
their effectiveness by the incorporation of cells and/or growth
factors adds further versatility to the design concept. Biolog-
ically active molecules, such as growth factors,need to be
added at the physiological temperature or below, since a
Fig. 7 Histological assessment of the CaP-coated mesh tubes and the
CaP-coated mesh tubes with BMP and PRP. H&E staining was per-
formed on longitudinal sections through the entire defect showing the
8-mm defect site with the adjacent host bone and the mesh (a/b). Bone
regeneration can be observed in the BMP group using H&E staining
(a,c,d) where the mesh is still visible (pale pink labelled “m”) with
adjacent mineralised bone tissue with embedded osteoblasts (osteo-
cytes) labelled “b” that indicates new bone formation. Von Kossa–
MacNeal's staining (g,h) shows clear black areas that correspond to
mineralised tissue. A high level of mineralisation can be seen through-
out the BMP group (g), which shows an overview of the defect area.
There is also evidence of cartilage tissue formation (c), which is
commonly a precursor tissue during endochondral ossification and is
subsequently mineralised to form bone. A small area of mineralisation
at the proximal and distal ends of the coated mesh group can be
observed (i,j). Dashed lines indicate defect site and are placed over
the image to indicate the edge of the host bone (dark pink)
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higher processing temperature may cause denaturation. Our
strategy to develop scaffold-based bone engineering has in-
volved the fabrication of an electrospun tubular construct,
which was then surface-modified and had the addition of
growth factors via PRP administration.
Given the appositional nature of bone formation, the
scaffold surface remains fundamental in bone tissue engi-
neering strategies. The surface modification of the nanofiber
mesh tubes with CaP coating demonstrated morphological
changes detected by SEM and microCT. The effects of
surface modification with calcium phosphate have received
mixed reviews in the literature. Some research groups show
positive effects of these coatings on bone regeneration and
the mechanical properties of the coated biomaterials (Liu et
al. 2011), whereas others show no beneficial effects of the
coating with respect to bone regeneration (Ekholm et al.
2005; Fontana et al. 2011). It should be noted, however,
that most of the defects treated in the aforementioned studies
were small bone defects (not critical-sized, thereby able to
heal unassisted) or were studies to demonstrate the effects of
surface modification on implant ingrowth (Fontana et al.
2011; Mihalko et al. 2010).
Our results show that the mesh-coated group didn’t show
any bridging of the defect or a large amount of bone forma-
tion, although some bone formation was evident. Also,
when compared to the uncoated mesh group (Supplementa-
ry Figure 1), there was more fibrous tissue within the defect
site when the nanofiber mesh was uncoated and very little
mineralisation was observed. CaP may abrogate the putative
foreign body giant cell response to the underlying polymer,
while the internal CaP phase provides dimensional stability.
Therefore, we conclude that the surface modification might
be helpful to support bone regeneration but the osteogenic
potency of the hydroxyapatite coating alone is not strong
enough to initiate bone regeneration in a critical-sized seg-
mental bone defect.
“Platelet-rich plasma” (PRP) was first used in the 1990s
as a pool of autogenous growth factors for bone regenera-
tion and there are now numerous studies showing the effect
of PRP on bone regeneration. However, a recent review
concluded that the supportive efficacy of PRP can be con-
sidered controversial (Redler et al. 2011); many studies were
able to demonstrate a positive effect, whereas others could
not. PRP does not exhibit any significant immunogenicity,
therefore it can be used in allogenic and xenogenic trans-
plantation. In our study, we choose pooled allogenic PRP to
assure that the PRP was uniform and homogenous and that
variations caused by inhomogeneous PRP could be avoided.
Nonetheless, numerous authors prefer autogenous PRP and
described it to be more potent. Our results in the present
study should be considered against this background.
These data demonstrate that platelet-rich plasma delivery
of BMP-7 within a nanofiber mesh tube resulted in robust
bone formation and complete bridging of the defects with
new bone. With this treatment, the bone volume and polar
moment of inertia were not significantly different from
uninjured controls, indicating full defect regeneration. Like-
wise, indicators of functional restoration, torsional stiffness
and maximum torque at failure were not significantly dif-
ferent from intact age-matched limbs, though the maximum
torque of the BMP group was approximately 60% of that of
controls. Taken together with the volumetric microCT data,
this suggests that the material strength of the newly formed
bone is lower than that of intact bone, probably due to the
presence of woven bone, which has an inherently lower
fracture toughness than lamellar cortical bone (Weiner and
Wagner 1998). However, it can be hypothesized that the
woven bone would continue to remodel over time and that
the final outcome would be a fully regenerated defect with
lamellar bone architecture.
Overall, these biomechanical, radiological and histologi-
cal results show that a CaP-coated tubular nanofiber mesh
loaded with PRP/BMP-7 is able to regenerate a large seg-
mental defect. Future studies have to be designed for up to at
least 6 months, to show that the woven bone formation
detected after 3 months, is completely remodelled into la-
mellar bone.
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